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sulfate depletion triggers 
overproduction of phospholipids 
and the release of outer membrane 
vesicles by Neisseria meningitidis
Matthias J. H. Gerritzen  1,2, Dirk E. Martens2, Joost P. Uittenbogaard3, René H. Wijffels2,4 & 
Michiel Stork  1
outer membrane vesicles (oMVs) produced by bacteria are interesting vaccine candidates. oMVs are 
nanoparticles that contain many immunogenic components, are self-adjuvating, and non-replicative. 
Despite recent insights in the biogenesis of OMVs, there is no consensus on a conserved mechanism of 
oMV release and the oMV yield from bacterial cultures remains low. For Neisseria meningitidis, a Gram-
negative human pathogen causing meningitis and sepsis, a feasible OMV production method based 
on triggering OMV release by cysteine depletion has been described. In this study, we investigated 
the mechanism behind this external trigger for oMV release to improve the production process. 
since enhanced oMV release upon cysteine depletion was associated with oxidative stress and redox 
responses, we investigate the influence of more oxidized sulfur sources on OMV release. We show 
that N. meningitidis grows similarly on sulfate, the most oxidized sulfur source, and OMV release is 
triggered by sulfur depletion in general. sulfate depletion induced increased release of oMVs over 
cysteine depletion. proteomics showed that sulfur depletion resulted in oxidative stress responses 
and upregulated phospholipid and LPS biosynthesis. Furthermore, OMVs produced by sulfur depletion 
were enriched in phospholipids. Mechanistically, we hypothesize that sulfur depletion results in 
overproduction of phospholipids causing increased bulging of the outer membrane and subsequent 
oMV release.
Outer membrane vesicles (OMVs) are spherical nanoparticles that contain the natural components of the bac-
terial outer membrane, including antigenic components1. OMVs have been effectively used as vaccines2–6. The 
OMV-based vaccines are currently not based on OMVs that are spontaneously released by the bacteria (sOMVs), 
but on vesicles extracted by a detergent (dOMVs). This extraction method was required to remove endotoxic 
lipopolysaccharides (LPS) from the OMVs, to make them suitable as vaccine. However, detergent extraction also 
caused a reduction in lipoproteins, reduced vesicle stability, and increased amounts of cytoplasmic components, 
all of which lower the vaccine quality7. Recently, LPS has been genetically engineered to reduce the toxicity of 
LPS by altering the LPS structure8,9. This approach of genetic LPS detoxification makes the detergent extraction 
obsolete and allows much milder detergent-free extraction methods. These milder OMV extraction methods can 
be used to produce detergent-free extracted OMVs (eOMVs) with improved yield, stability and immunogenicity 
as compared to dOMVs10,11. Alternatively, genetic detoxification of LPS also allows the use of sOMVs as vaccines.
Using sOMV over eOMVs simplifies the vesicle production process. OMV extraction requires several addi-
tional unit operations while sOMVs could be directly obtained from the culture supernatant. Another advantage 
of using spontaneous vesicles as vaccines is the enhanced immunogenicity of the vesicles10. Compared to both 
eOMVs and dOMVs, the immune response against sOMVs from Neisseria meningitidis (Nm) is higher and shows 
a broader cross-protection against PorA types that are not included in the vesicles itself10. sOMV production 
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however, is challenging since typical sOMV productivity is low. The release of OMVs has been proposed as a 
regulated mechanism based on the observation that OMVs differ in protein composition from the bacterial outer 
membrane12–16. Many biological functions have been ascribed to OMVs, that are advantageous for the survival 
chances of the bacterium by for example delivery of virulence factors or modulation of host immune response1,17. 
Progression in understanding OMV biogenesis has been made, however the mechanism of OMV formation 
remains unclear and even the question remains whether a conserved mechanism exists7,18. The biogenesis of 
OMVs has been categorized in three models19. In a first model, OMV release is based on the maintenance of 
lipid asymmetry in the outer membrane, that is based on increased phospholipid content in the outer leaflet of 
the outer membrane instead of LPS. A second model proposes that OMV release is induced by misfolded and 
unfolded proteins in the periplasm. In a third model, OMV formation is induced by alterations in the stability of 
the outer membrane due to LPS modifications.
Since the exact biogenesis of OMVs remains unknown, engineering approaches were applied to improve 
OMV productivity. One approach is based on the observation of increased vesicle release by strains with a 
reduced linkage of the outer membrane to the peptidoglycan1. It has been shown for several bacterial species that 
reducing the outer membrane (OM)-peptidoglycan linkage, by knockout mutation of membrane anchoring pro-
teins, increases the release of OMVs10,20–23. In this work, we use the knockout of the membrane anchoring RmpM 
protein to increase the sOMV release of Nm. Additionally, we showed previously that cysteine depletion could be 
used as external trigger of Nm OMV release in a batch culture24. Cysteine depletion resulted in impaired sulfur 
supply, the onset of the stationary growth phase, oxidative stress as shown by upregulation of genes involved in 
oxidative stress responses, and in an increased OMV release. However, the mechanism of this increased vesicle 
formation remains unknown.
Based on the fact that oxidative stress responses seem to be involved in OMV release, we hypothesize that 
the oxidation state of the sulfur source affects the release of OMVs. Sulfur is an essential component of proteins 
and the sulfur metabolism of Nm has been extensively studied25–28. Originally it was described that reduced 
sulfur (cysteine or cystine) is necessary for growth25,26, and Catlin described an absolute requirement of cysteine 
for growth of a few Nm strains29. However, growth of Neisseria on the oxidized sulfur source sulfate has been 
shown27,28, indicating that Nm metabolism is capable of sulfate reduction. The cysteine biosynthesis in Neisseria 
species has been recently reviewed30. For the assimilation of cysteine from sulfate, sulfate is converted to aden-
osine 5′-phosphosulfate (APS) and via phosphoadenosine-5′-phosphosulfate (PAPS) the sulfur is reduced to 
sulfite31. After further reduction of sulfite to hydrogen sulfide the sulfur is incorporated in cysteine. It has been 
proposed that the Nm pathway may differ slightly from the described classical cysteine assimilatory pathway, 
since APS could be directly reduced to sulfite without PAPS as intermediate31. Besides sulfate, thiosulfate can be 
used as well for the assimilation of sulfur source since the presence of thiosulfate reductase has been shown28. 
Growth of Nm on oxidized sulfur sources is thus possible and the availability of multiple sulfur-acquisition routes 
illustrates the importance of sulfur in the metabolism of meningococci.
This study aims to increase the understanding of OMV formation in Nm triggered by sulfur depletion by 
looking at the influence of different sulfur sources on OMV release upon sulfur depletion. First, we assess growth 
of Nm on sulfate as the sole sulfur source in a chemically defined medium. Next, the effect of cysteine and sulfate 
depletion is assessed by proteomics. Lastly, to gain further insight in the mechanism of OMV biogenesis upon 
sulfur-source depletion, the biochemical composition of OMVs produced in different growth phases and upon 
both cysteine and sulfate depletion was assessed.
Results
Influence of sulfur depletion on sOMV release. After initial adaptation of Nm on sulfate, growth on 
other oxidized sulfur sources such as sulfite and thiosulfate was also possible without the requirement of an addi-
tional adaptation phase. Growth in shaker flasks on oxidized sulfur sources was comparable to growth on cysteine 
(Data not shown). Growth on sulfate, the most oxidized sulfur source was compared to growth on the preferred 
(reduced) sulfur source cysteine in benchtop bioreactor cultures. The dissolved oxygen tension of the cultures was 
controlled at 30% air saturation. The growth pattern of Nm on sulfate shows exponential growth with an average 
specific growth rate of 0.47 h−1 until the maximum optical density in this medium is reached (Fig. 1A). The aver-
age specific growth rate on cysteine is similar, 0.46 h−1. The carbon dioxide production pattern of the cultivation 
on both sulfur sources shows the typical pattern of a batch culture, with a respiratory quotient of 1.0 throughout 
the culture. Previously it was shown that cysteine depletion causes growth arrest24 and with similar biomass yields 
on sulfate we assume sulfate limitation is the cause of the onset of the stationary phase of the sulfate based culture. 
At this point in both cultures, other nutrients like the carbon, nitrogen, and phosphate source are still available 
in abundance (data not shown). Both cultures show minimal OMV release during the exponential growth phase 
(Fig. 1B). In the stationary phase both cultures produce sOMVs. However, the sOMV release upon sulfate deple-
tion showed higher than during cysteine depletion.
proteome analysis of cysteine and sulfate depleted batch cultures. To understand how the bacte-
rium copes with the onset of sulfur depletion during cultivation, the proteome was examined. Triplicate bioreac-
tor cultures with either cysteine or sulfate as sole sulfur source were analyzed at different time-points during the 
cultivation (Fig. 2A). Culture supernatants showed depletion of the corresponding sulfur source at 7 h (Fig. 2A, 
time-point t2). Sulfur depletion results in increased OMV concentrations in the culture (Fig. 2B), confirming the 
previous results (Fig. 1). During growth in the presence of cysteine (t1), the proteome of Nm shows no upregu-
lation of the cysteine biosynthesis pathway as expected as cysteine is sufficiently available (Fig. 2C, Supplemental 
File 1 for the complete dataset). The pathway is also not upregulated when cysteine becomes limiting (t3-t5), pos-
sibly because no sulfur is available for the generation of new proteins, or since no other sulfur source is available. 
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Figure 1. Growth and sOMV release of Nm during sulfur source depletion. Nm cultures are grown on cysteine 
(black) and sulfate (green) as sulfur source. The growth curve based on optical density is shown in graph 
(A), and the concentration of OMV is given in graph (B). Graphs are the overlay of two replicate cultures to 
practically allow for sufficient data points covering 24 h.
Figure 2. Experimental approach for proteomics. Triplicate Nm batch cultures on cysteine or sulfate as the 
sole sulfur source were sampled during exponential growth (t1, t2), onset stationary phase (t3, t4), and late 
stationary phase (t5) (A). The OMV concentration was measured by NTA throughout the cultivation (B). Error 
bars indicate standard deviation from the mean. The proteome is assessed for the cysteine assimilation pathway 
as shown in the heat map (C).
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CysW, CysT and CysH were below the detection limit of the LC-MS/MS analysis. During growth on sulfate the 
cysteine biosynthesis pathway was upregulated throughout the cultivation as expected.
We then performed gene ontology enrichment on the proteome data. Proteins categorized in the gene ontol-
ogy antioxidant activity (GO:16209) were found to be upregulated upon cysteine depletion (time points t3, t4) 
(Fig. 3). This agrees to the previously described antioxidant and redox-stress responses found in the transcrip-
tome upon cysteine depletion24. Upon sulfate depletion proteins with antioxidant activity are upregulated as well. 
Upon cysteine depletion, AhpD and AhpC are upregulated. Upon sulfate depletion these appear not to be regu-
lated, while another protein with ascribed alkylhydroxyperoxidase activity (ahpD, E6MUC5) was observed to be 
regulated on sulfate as sulfur source. Proteins involved in phospholipid (GO:8654), fatty acid and LPS production 
(GO:9103) were upregulated after both cysteine depletion and sulfate depletion, simultaneously with increased 
OMV release. Both phospholipid biosynthesis and fatty acid biosynthesis proteins were more upregulated after 
sulfate depletion than after cysteine depletion. This upregulation is consistent with the increased release of OMV 
observed after sulfate depletion. Interestingly, the VacJ/Yrb ABC (ATP-binding cassette) transporter, which has 
a proposed role in maintaining lipid asymmetry in the outer membrane by transport of phospholipids from the 
outer leaflet to the inner leaflet, is strongly upregulated upon growth on sulfate as sulfur source, and is not regu-
lated upon cysteine depletion.
Figure 3. Heat maps based on gene ontology. Heat maps for specific gene ontology groups from the proteome 
dataset. The gene ontologies for antioxidant activity (GO:16209), Fatty acid biosynthesis (GO:6633), LPS 
biosynthesis (GO:9103), and phospholipid biosynthesis (GO:8654) are shown. Additionally, the expression level 
is shown of the VacJ/Yrb ABC transport system. VacJ was included although it was only detected in 8 out of 10 
time-points, since the VacJ levels were near the detection limit in the cysteine culture. Samples indicated by “nd” 
were not detected.
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sulfur depletion results in phospholipid enriched oMVs. During OMV production as a result of sul-
fur depletion, increased phospholipid production takes place, which could result in OMVs enriched in phos-
pholipid content. This changed composition of the OMVs could also affect their size. To test this, OMVs were 
isolated from batch cultures containing either sulfate or cysteine, during the exponential growth phase, onset of 
the stationary phase and in the stationary phase. The size of OMVs was measured by NTA and was found to be 
similar throughout the cultivation and between sulfate depletion and cysteine depletion (Fig. 4A). A small trend 
in increased OMV size upon sulfur depletion was observed, although non-significant. The phospholipid content 
of OMVs increased upon sulfate depletion, while upon cysteine depletion the phospholipid content only shows 
a minor increase (Fig. 4B). The relative content of LPS, based on fatty acid analysis, decreased similarly for both 
sulfate and cysteine depletion (Fig. 4C).
Discussion
This study shows that not cysteine depletion specific, but sulfur depletion in general induces OMV release in Nm 
cultures. Growth of Nm on sulfate was comparable to growth on cysteine as sulfur source. Upon sulfur depletion, 
the proteome showed increases in antioxidant activity, phospholipid biosynthesis and LPS biosynthesis. OMVs 
released after sulfur depletion were enriched in phospholipids. The most interesting finding was that sulfate 
depleted cultures showed increased OMV release over cysteine depleted cultures.
OMV formation upon sulfur depletion can be the result of increased phospholipid biosynthesis. Especially 
OMVs produced after sulfate depletion showed to be enriched in phospholipids. This finding was supported by 
the increased phospholipid biosynthesis observed in the proteome. Recently, an important role was shown for 
the VacJ/Yrb ABC (ATP-binding cassette) transporter in OMV biogenesis16. This transporter has a proposed role 
in maintaining lipid asymmetry in the outer membranes as phospholipid transporter32, by transporting phos-
pholipids from the outer leaflet of the membrane to the inner leaflet, and is annotated in the Nm genome. It 
was shown by Roier et al. that the VacJ/Yrb ABC transporter was downregulated by the ferric uptake regulator 
(FUR) upon iron limitation in H. influenzae, V. cholerae and E. coli16. Disruptions of the VacJ/Yrb ABC transport 
system resulted in increased OMV formation, due to phospholipid accumulation in the outer membrane. This 
increase in OMV production in H. influenzae was not accompanied with increased fatty acid biosynthesis. In 
this study we show that sulfur depletion causes increased release of OMVs that are enriched in phospholipids. It 
should be noted that we used a strain with reduced linkage between the peptidoglycan and the outer membrane 
(rmpM knockout mutant). Interestingly, our Nm proteomics data upon sOMV formation by sulfate depletion 
showed simultaneous upregulation of the VacJ/Yrb ABC transporter and phospholipid biosynthesis. Possibly, 
this transporter is upregulated to counteract the accumulation of phospholipids in the outer membrane due to 
the increased synthesis and stop of growth. The overproduction of OMVs could be a method to dispose of the 
excess phospholipids in the outer membrane because the transporter has insufficient capacity. This suggests that 
upon sulfur depletion, OMV release is triggered in a different manner than downregulation of the VacJ/Yrb ABC 
transport system. Although it does support the OMV biogenesis model of phospholipid accumulation based 
OMV release19.
The increased phospholipid production upon growth on sulfate can be a result of the altered redox state. 
During cysteine assimilation from sulfate, NADPH is required to reduce the oxidized sulfur source30. NADPH 
replenishment is thus higher during growth on sulfate, than for growth on cysteine. We hypothesize that upon 
sulfate depletion the high NADPH replenishment causes a surplus of NADPH since no NADPH is used anymore 
for cysteine assimilation . Phospholipid production, which also requires NAPDH, is then increased as a sink for 
the NAPDH that is produced in excess. As NADPH is one of the key cofactors in the metabolic network and 
influenced by many reactions33 it can be argued whether a short perturbation causes a prolonged state of OMV 
release. After sulfur depletion, increased levels of serine could be expected since no sulfide is available anymore 
to produce cysteine. Besides conversion to cysteine, serine can be used for the production of phospholipids by the 
conversion to phosphatidylserine. Engineering the redox metabolism is a method for enhanced lipid production 
Figure 4. OMV characteristics upon sulfur depletion. OMV size by Nanoparticle Tracking Analysis of purified 
sOMV at different growth stages of the batch cultures on cysteine and sulfate (A). Error bars indicate standard 
deviation of the mean of 10 measurements. The biochemical composition of OMVs produced upon sulfur 
depletion show increased phospholipid/OMV ratio (B). The fatty acid distribution between phospholipid and 
LPS is shown upon sulfur source depletion (C).
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in microbes34. For example, lipid production in Yarrowia lipolytica has been boosted by introduction of path-
ways that convert NADH to NADPH35. Another important role of NADPH is as cofactor of enzymes involved 
in oxidative stress responses as catalase, superoxide dismutase and glutathione peroxidase36. Alternatively, the 
increased phospholipid production can be required to maintain the membrane integrity because of the increased 
OMV release. Moreover, sulfur depletion could stimulate OMV release through a secondary mechanism such as 
oxidative stress. Sulfur is an important component of major oxidative stress responses37 and sulfur starvation may 
induce OMV release by affecting these oxidative stress responses. Oxidative stress responses were observed in the 
gene expression profile after cysteine depletion previously24. As sulfur was unavailable, glutathione biogenesis and 
iron-sulfur protein biogenesis was impaired. Biologically, Nm encounters sudden oxidative stress in the oxidative 
burst that phagocytes apply to eliminate invading pathogens37,38. Increased OMV release upon oxidative stress 
can be a method to release oxidative stress or a method to enhance survival upon oxidative bursts.
OMV formation as a result of nutrient limitation has been posed as an evolutionary trigger for OMV release 
as survival is enhanced through nutrient scavenging39. Recently, amino acid deprivation was found to stimu-
late OMV and tubular OMV structures in Francisella tularensis40. Nm OMVs have been found associated with 
iron-scavenging proteins41 and Bacteroides succinogenes OMVs have been found to contain xylanases or cellulases 
that can assist in nutrient acquisition42. OMV formation upon nutrient limitation may thus assist in nutrient 
acquisition and improve bacterial survival.
The size of OMVs was similar for OMVs produced after depletion of sulfate and cysteine, while OMV size can 
be highly subjectable to changes. The induction of OMV release of Pseudomonas aeruginosa by gentamycin yields 
enlarged OMVs15,43. Mitomycin C treatment of Shigella dysenteriae induces the release of larger OMVs44. The size 
of OMVs can affect both the production process of OMVs, as it influences purification and analysis of OMVs, 
and the immunogenicity as the size influences the uptake by antigen presenting cells45. The observed similarity 
in size distribution of OMVs in this study is somewhat surprising as the vesicles produced upon sulfate deple-
tion where enriched in phospholipids. This results in a lower content of LPS, which could affect the use of these 
OMVs as vaccines. The biological activity of native Nm LPS is high, as characterized by its activation of the TLR4/
MD-2 complex. LPS can be engineered such, by changes in lipid A acylation and phosphorylation, that these LPS 
derivates have various strengths of TLR4/MD-2 activation46. Future work should tune the required LPS activity 
of these spontaneously released OMVs with reduced LPS content to optimize the amount of immune activation 
while limiting toxic side effects for an optimal vaccine composition.
Taken together, the findings of this study expand the knowledge on OMV release by Nm. Sulfur depletion can 
be used as general mechanism to trigger vesicle formation in Nm and the use of sulfate as sulfur source improves 
the OMV productivity of Nm batch cultures. Sulfur depletion caused overproduction of phospholipids and espe-
cially sulfate depletion resulted in OMVs enriched in phospholipid content. OMV biogenesis remains a compli-
cated and poorly understood process that leaves many research questions remaining. Refined understanding of 
OMV biogenesis will boost production processes of OMVs released in the supernatant of bacterial cultures and 
will ultimately make OMV extraction processes obsolete for the production of OMV-based vaccines.
Materials and Methods
Shaker flask cultures. A recombinant derivate of the Neisseria meningitidis serogroup B isolate H44/7647 
was used in this study. This strain had a non-encapsulated phenotype due to the siaD knockout, lpxL1 deletion 
to attenuate LPS-toxicity, rmpM deletion to improve vesicle formation and lgtB was mutated to skew towards 
dendritic cells10,48. The selected strain was a PorA lacking derivate of the H44/76 isolate. This strain was stored 
in a two-tiered seedlot system containing glycerol at −135 °C. All cultivations were performed with chemically 
defined growth medium49. Growth on sulfate, sulfite and thiosulfate was performed with adapted strains since 
cysteine is the preferred sulfur source. Adaptation was performed by subculturing the strain in shaker flasks in 
medium without cysteine (Supplemental Fig. 1). Initial growth was observed, possibly caused by carryover of 
cysteine, followed by an adaptation phase of 26 hours. After exponential growth on sulfate was observed, the 
culture was subcultured on medium with sulfate as the only sulfur source and cryopreserved for further experi-
ments. Shaker flask cultivations of 150 mL were performed in 500 mL baffled shaker flasks incubated at 200 RPM 
at 35 °C. Cultures were inoculated from a shaker flask culture in the exponential growth phase. Samples with a 
fixed volume of 2.0 mL were taken for optical density measurements (590 nm), pH measurements and used for 
sOMV concentration measurements after sterile filtration (0.22 µm) and storage at 4 °C.
Bioreactor cultures. Batch cultivations were performed in 5 liter dished bottom Applikon bioreactors with 
an H/D ratio of 1.6 based on total volume. Cultivations with a 3 liter working volume were operated from a Pierre 
Guerin Trytoni controller. Temperature was controlled at 35 ± 0.5 °C and pH was controlled at pH 7.2 ± 0.05 
using 1M HCl and 1M NaOH as titrant. Dissolved oxygen tension (DOT) was controlled at 30%. In the first 
phase of the cultivation, DOT is controlled by the stirrer (300–1000 RPM) and next the fraction of oxygen is 
increased in the headspace aeration (1 NL/min). Samples were taken for optical density measurements and used 
for nutrient and sOMV concentration measurements after sterile filtration (0.22 µm) and storage at 4 °C. Offgas 
composition was measured by a Thermo Scientific Prima δb process mass spectrometer.
proteomics. Protein Digestion: bacterial suspensions were denaturated at 100 °C for 30 min in a potassium 
phosphate buffer (100 mM, pH 7.8) containing 0.1% Rapigest (Waters) at a protein concentration 0.2 mg/mL. 
Proteins were digested with 0.25 µg endoproteinase Lys-C (Roche) at 37 °C for 4 h followed by overnight digestion 
with 1 μg trypsin (Promega) at 37 °C.
Peptide Labeling: relative quantification of proteins in protein samples was performed using dimethyl labeling 
as described previously50. In brief, protein digests were incubated with NaCNBH3 and formaldehyde (CH2O) in 
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concentrations of 50 mM. The common reference was prepared from 20 μg of each unlabeled digest. The common 
reference was incubated with NaCNBH3 and deuterium-labeled formaldehyde (CD2O) in final concentrations of 
50 mM. The dimethylated (light) peptide samples were mixed with the deuterium dimethylated (heavy) common 
reference in a 1:1 molar ratio. Solid phase extraction was used to purify the samples using 1 mL Sep-Pack C18 
cartridges and water/acetonitrile/formic acid (40/59.9/0.1%) eluent. Vacuum centrifuge dried peptide mixtures 
were dissolved in 100 μL water/DMSO/formic acid (94.9/5/0.1%) and diluted 1:20 in water/DMSO/Formic acid 
(94.9/5/0.1%).
LC−MS/MS Analysis: Nanoscale reversed-phase liquid chromatography electrospray mass spectrometry was 
used to identify peptides using an Orbitrap Fusion Lumos (Thermo Scientific, USA) and Agilent 1290 (Agilent 
Technologies, USA), as described previously51. Full MS spectra were recorded in the Orbitrap with a resolution of 
120 000 (fwhm) (m/z 300−1500) and the 20 most abundant precursors (with a threshold of 25000 counts) were 
CID fragmented and analyzed in the ion trap. The setpoints of collision energy, isolation width, and isolation off-
set were set to 35%, 1.6 Da and 0.25 Da respectively. The MD data was processed with Proteome Discoverer 2.2. 
MS/MS spectra were searched against the N. meningitidis H44/76 (NCBI 909420) database with trypsin enzyme 
specificity and a mass tolerance of 5 ppm for precursor ions and 0.4 for fragment ions. The FDR was set to 1% 
using the Percolator algorithm (Thermo Scientific). Abundance ratios of the proteins were determined with the 
default dimethyl quantification workflow of Proteome Discoverer using the dimethyl (C1H3)2 (+28.03130 Da) 
and (C1D2H1)2 (+32.05641 Da) channels.
The protein abundance ratios of the biological triplicates were excluded from the dataset if the protein was 
detected in less than two out of three replicates. This resulted in a dataset of 621 proteins that were detected in all 
time-points of the samples. The abundance ratios of the proteins were log2 transformed to obtain fold changes 
and heat maps were generated.
OMV purification. From the bioreactor cultures, 50 mL samples were obtained. Samples were centrifuged 
for 20 minutes at 3000 × g, 4 °C, to separate bacteria from the OMV containing supernatant. Next, the superna-
tant was filtered over a 0.2 µm filter (Nalgene Rapid Flow, PES) and the sterile OMV fraction was concentrated 
and washed with one volume of 0.01M Tris buffer pH 7.4 containing 3% sucrose on 100 kDa MWCO Amicon 
Ultra-15 Centrifugal Filter Units according to manufacturer’s protocol (Merck Millipore). Lastly, the OMVs were 
pelleted by ultracentrifugation (125,000 × g, 2 h, 4 °C) and the OMV pellet was resuspended in a 0.01M Tris buffer 
pH 7.4 containing 3% sucrose.
oMV composition. Phospholipid and LPS content was analyzed by fatty acid composition measurement 
using a modified gas chromatography method as described previously10. LPS quantification was based on the 
peak area of C14:3OH (two molecules per LPS moiety) using C12:0-3OH as internal standard. Phospholipid 
was quantified by the sum of the peak areas C16:0, C16:1, C18:0 and C18:1 using C15:0 as the internal standard.
Nanoparticle tracking analysis. To analyze purified sOMVs, a NanoSight NS500 (Malvern Instruments) 
with 488 nm wavelength laser module and sCMOS camera was used for nanoparticle tracking analysis (NTA)52. 
A sample was measured in static mode by capturing 10 movies of 30-seconds with temperature control at 25 °C. 
Movies were analyzed in the NTA 3.2 software build 3.2.16. The NS500 was calibrated by the NanoSight NTA 
concentration Measurement upgrade. The sample changer was used to increase the throughput of samples meas-
ured53. The NS500 is cleaned monthly with Decon 90, following the manufacturers recommendations. Before 
every set of sample measurements, we confirmed the absence of particles in the MilliQ diluent by measuring the 
MilliQ diluent for 60 seconds in static mode.
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